Study Shows new drug helps elderly with insomniaJuly 25, 2006WINSTON-SALEM, N.C. - The drug eszopiclone, marketed as Lunesta, significantly improved sleep in elderly people with chronic insomnia, according to a report by W. Vaughn McCall, M.D., M.S., and six colleagues. "Eszopiclone was well tolerated and significantly improved sleep onset, sleep efficiency, total sleep time and sleep quality over the study period," said McCall, director of the sleep laboratory at Wake Forest University Baptist Medical Center and professor and chairman of the Department of Psychiatry and Behavioral Medicine, in the study published in Current Medical Research and Opinion. He said eszopiclone significantly reduced wakefulness after sleep had begun, wake time during the sleep period and daytime napping. McCall said daytime napping was more common in elderly patients with insomnia than in good sleepers and that napping increases with age. "The finding of less daytime napping associated with eszopiclone treatment in the present study could be interpreted as evidence of improvement in some aspects of daytime function in these elderly insomniacs." The study compared eszopiclone with an inert placebo in patients 64 to 86 years old over a two-week period and used both measurements made in sleep laboratories and patients' own reports of their sleep activity during the study. The 136 patients in the eszopiclone group reported greater quality of sleep and greater depth of sleep than the 128 patients in the control group, he said. "Upon awakening, patients treated with eszopiclone reported less morning sleepiness compared with placebo." Since patients were in the study for only two weeks, McCall said longer-term studies are needed to determine the safety of longer treatment. The study - conducted in 49 sleep laboratories - was the largest sleep-lab-based trial of nightly doses of a sleeping pill in elderly patients with insomnia, he said. "Chronic insomnia is an under-recognized, under-diagnosed and under-treated disorder that is not only more prevalent in the elderly than the general population, but also potentially serious, as it can be associated with increased risk for injurious falls and impairment of cognitive function, which can be misdiagnosed as dementia," McCall and his colleagues said. "In patients with dementia, insomnia is also the most frequently cited reason for nursing home placement." Wake Forest University Baptist Medical Center |
|||||||||||||||||||||
| Related Insomnia Current Events and Insomnia News Articles Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center. Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation. Exercise reduces fatigue in cancer patients undergoing chemotherapy Supervised exercise programmes that include high and low intense cardiovascular and resistance training can help reduce fatigue in patients with cancer who are undergoing adjuvant chemotherapy or treatment for advanced disease. U-M discovery about biological clocks overturns long-held theory University of Michigan mathematicians and their British colleagues say they have identified the signal that the brain sends to the rest of the body to control biological rhythms, a finding that overturns a long-held theory about our internal clock. Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. Penn studies point to strategies for reducing painful breast cancer drug side effects Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. 'Alert status' area in brain discoved by Hebrew University scientists A new understanding of how anesthesia and anesthesia-like states are controlled in the brain opens the door to possible new future treatments of various states of loss of consciousness, such as reversible coma, according to Hebrew University of Jerusalem scientists. Insomnia is bad for the heart Can't sleep at night? A new study published in the journal Sleep has found that people who suffer from insomnia have heightened nighttime blood pressure, which can lead to cardiac problems. Workplace bullying is associated with sleep disturbances A study in the Sept.1 issue of the journal SLEEP shows that current or past exposure to workplace bullying is associated with increased sleep disturbances. Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women A study in the Sept.1 issue of the journal Sleep shows that the sleep-wake activity rhythms of breast cancer patients are impaired during the administration of chemotherapy. More Insomnia Current Events and Insomnia News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||